Asymbescaline
 | This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Asymbescaline" – news · newspapers · books · scholar · JSTOR (August 2019) |
 | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name
2-(3,4-Diethoxy-5-methoxyphenyl)ethan-1-amine | |
| Other names
3,4-Diethoxy-5-methoxyphenethylamine
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| ChemSpider |
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.315 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Asymbescaline (3,4-diethoxy-5-methoxyphenethylamine) is a lesser-known psychedelic drug. It is a homolog of mescaline. Asymbescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 200–280 mg, and the duration listed as 10–15 hours.[1] Asymbescaline produces few to no effects.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of asymbescaline.
See also
References
External links
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.